Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study

The unplanned use of dual induction therapy with interleukin-2 receptor-blocking antibodies (IL2rAb) and antithymocyte globulin (ATG) may portend adverse outcomes. METHODS. We used national transplant registry data to study clinical correlates and outcomes of single versus dual induction therapy in...

Descripción completa

Detalles Bibliográficos
Autores principales: Lam, Ngan N., Jeong, Rachel, Quinn, Robert R., Ravani, Pietro, Xiao, Huiling, McAdams-DeMarco, Mara, Axelrod, David A., Schnitzler, Mark A., Snyder, Jon J., Lentine, Krista L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Kidney Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276156/
https://www.ncbi.nlm.nih.gov/pubmed/35836670
http://dx.doi.org/10.1097/TXD.0000000000001190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276156/
https://www.ncbi.nlm.nih.gov/pubmed/35836670
http://dx.doi.org/10.1097/TXD.0000000000001190

Ejemplares similares